1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. ALLOGENE THERAPEUTICS INC
Allogene Therapeutics Inc XNAS: ALLO

Allogene Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

about

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-c...

Read More
1.77 0.05 (2.91%)
53.17% Fall from 52W High
6.8M
XNAS Volume

XNAS 23 Jan, 2026 3:18 PM (EST)

Watchlist

Portfolio

Alert
Durability score
Not Eligible
Valuation Score
Expensive Valuation
12.7 / 100
Momentum Score
Technically Moderately Bullish
68.0 / 100
Analyst Price Target
7
1Yr Price target upside is 317%
12 analysts

20

S

5

W

6

O

0

T

SWOT Analysis

Allogene Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..